SUSAN E. WHEATON, M.D.

  Mercy Hospital Laboratory

4050 Coon Rapids Blvd
Coon Rapids, MN 55433

(763) 236-8197

fax (763) 236-8277

PROFESSIONAL TRAINING AND EXPERIENCE

• Staff Pathologist, Hospital Pathology Associates, St Paul, MN, August 1997-present

EDUCATION  

• Fellow, Hematopathology, University of Utah, 1996-1997

• Chief Resident, Pathology Residency Program, McGaw Medical Center of Northwestern University, Chicago, IL, 1994-1995

• Credentialing year in Hematopathology, Pathology residency 5th year training, McGaw Medical Center of Northwestern University, Chicago, IL, 1994-1995

• Resident, combined Anatomic and Clinical Pathology, McGaw Medical Center of Northwestern University, Chicago, IL, 1991-1996

• M.D., Rush Medical College, Chicago, IL, 1991

PROFESSIONAL CERTIFICATIONS

• Anatomic and Clinical Pathology, 1996

• Hematopathology, 1997

LICENSURE

• State of Minnesota, 1997

PROFESSIONAL AFFILIATIONS

• College of American Pathologists

• Society for Hematopathology

• American Association of Blood Banks

• Hennepin County Medical Society

• Minnesota Medical Association
• Minnesota Society of Pathologists
• Twin Cities Society of Pathologists

PUBLICATIONS AND ABSTRACTS

• Hirschtick R, Dyrda S, Peterson L: The use of unconventiona1 therapy in patients with acquired immunodeficiency syndrome. Ann of Int Med 120 (8): 694, 1994.

•  Tallman MS. Hakimian D, Dyrda S, Kiley C. Peterson L: Detection of minimal residual disease in patients with hairy cell leukemia after treatment with 2-chlorodeoxyadenolinc using immunostaining and measurement of splenic index. Leukemia Lymphoma 14: 133-8, 1994.

• Wheaton S, Tallman MS, Hakimian D,Peterson L: Minimal residual disease at three months may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine, Blood: Feb 1996

• Tallman MS, Hakimian D, Kopecky K, Wheaton S, Wollins E, Foucar K, Cassileth P, Habermann T, Grever M, Rowe J. Peterson L: Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-Chlorodeoxyadcnosine or 2-Deoxycoformycin and prediction of relapse.

• Netser J, Wheaton S, Guinee D, Perkins S: BAX protein expression in non-Hodgkin’s Lymphomas.  

• Dyrda S, Cajulis R, Hidveji D: Spectum of morphologic changes in thyroid nodules secondary to fine needle aspiration. Modern Pathology 7 (1): 3SA, 1994.

• Dyrda S, Tallman M, Hakimian D, Peterson L: Immunohistochemical detection of minimal residual disease in patients with hairy cell leukemia treated with 2-CdA correlates with relapse. Modern Pathology 7 (1): l07A. 1994.

• Wheaton S, Rahne M, Perkins S: BCL-2 lmmunostaining demonstrates the spectrum of mantle B-cell and T-cell ingression in progressive transformation of germinal centers. Accepted to the International Academy of Pathology meeting, March 1997.

• Dunphy CH, Wheaton S, Perkins S: CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Accepted to the International Academy of Pathology meeting, March 1991.

PRESENTATIONS

• "Aggressive Osteoblastoma vs. low-grade Osteosarcoma", Illinois Registry of Anatomic Pathology, November 1994

•  “Detection of Minimal Residual Disease in Patients with Hairy Cell Leukemia”, Northwestern University Blood Club, May 1995

• "Marginal Cell Lymphoma of Spleen”, Utah Society of Pathology, September 1996